How Much Does Wegovy Cost in 2026? Insurance, Coupons, and Cash-Pay Pricing

Wegovy is the original FDA-approved GLP-1 for chronic weight management, and it remains one of the most prescribed weight loss medications in the country. It is also one of the most expensive: the retail price hovers around $1,349 per month, which puts it out of reach for most Americans paying cash. The good news is that there are now four legitimate paths to a much lower monthly cost in 2026, and the gap between cheapest and most expensive is significant.

Here is the complete breakdown of what Wegovy actually costs in 2026, including the savings programs, insurance pathways, and telehealth alternatives that can drop your monthly bill from $1,349 to as little as $0.

Wegovy Pricing at a Glance (2026)

The Cash-Pay Reality: $1,349/Month at Retail

If you walk into a pharmacy with a Wegovy prescription and no insurance, the average cash price is around $1,349 for a one-month supply (4 single-dose pens, regardless of dose strength from 0.25 mg to 2.4 mg).

That is a brutal price point, especially because GLP-1 medications work best as long-term therapy. The STEP 1 trial that established Wegovy's weight loss credentials showed that participants who stopped the medication regained about two-thirds of their weight within a year. The medication is most effective when taken indefinitely, which makes the recurring monthly cost a permanent line item.

Path 1: Commercial Insurance + the Wegovy Savings Card

This is the cheapest path for most people who qualify. It requires commercial insurance (not Medicare, Medicaid, Tricare, or VA coverage) and a plan that covers Wegovy.

How it works:

1. Your doctor writes a Wegovy prescription
2. Your insurance plan approves the prescription, often after prior authorization documenting your BMI and weight-loss attempts
3. You apply the Novo Nordisk Wegovy Savings Card at the pharmacy

With this stack, your out-of-pocket cost can drop to as low as $0 per month for a 1-month supply if you have full insurance coverage. The savings card covers up to $500 per fill, capped at maximum savings per year. Without insurance coverage but with the savings card, you can save up to $500 per fill, bringing the cost from $1,349 to roughly $849 per month.

The catch: about 40-50 percent of commercial plans do not cover Wegovy for weight loss. Some plans cover Wegovy but not Zepbound, others cover Zepbound but not Wegovy, and some cover neither. Check your specific plan formulary before assuming coverage.

Path 2: NovoCare Pharmacy Direct-to-Consumer

Novo Nordisk launched NovoCare Pharmacy in mid-2025 as a direct-to-consumer option for cash-pay patients. Patients receive Wegovy single-dose pens shipped directly from the manufacturer.

Pricing as of 2026: $499 per month for all dose strengths.

This is the cheapest brand-name Wegovy option for cash-pay patients without commercial insurance. The pricing is flat across all doses, so the cost does not increase as you titrate up to the maintenance dose.

Path 3: Compounded Semaglutide Through Telehealth

This is where the biggest savings live. Compounded semaglutide remains widely available in 2026 because semaglutide stayed on the FDA shortage list longer than tirzepatide, allowing licensed compounding pharmacies to continue producing it for personal use.

Telehealth providers offering compounded semaglutide in 2026:

The trade-offs:

• Insurance does not cover compounded versions — you pay cash regardless of your insurance status
• Pharmacy quality variability between facilities; choose providers using PCAB-accredited 503A or 503B compounding pharmacies
• Regulatory uncertainty if FDA officially declares the semaglutide shortage resolved
• Vial-and-syringe administration instead of pre-filled pens

For most patients without insurance coverage, compounded semaglutide at $99-$199 per month is the most affordable legitimate path to GLP-1 therapy in 2026.

For a deeper look at the trade-offs, see our brand-name vs compounded GLP-1 cost comparison.

Path 4: Ozempic Off-Label

Ozempic and Wegovy contain the same active ingredient (semaglutide) but are FDA-approved for different conditions. Ozempic is approved for type 2 diabetes; Wegovy is approved for weight loss. Some doctors prescribe Ozempic off-label for weight loss, particularly for patients whose insurance covers Ozempic for diabetes but not Wegovy for weight loss.

Pricing is similar: Ozempic retails at approximately $1,000 per month, with a similar Novo Nordisk savings program. The off-label workaround is most useful for patients with prediabetes, insulin resistance, or type 2 diabetes diagnoses where Ozempic is more likely to be covered.

Insurance Coverage in 2026

Medicare Part D: Starting July 2026, Medicare Part D plans will cover GLP-1 medications for chronic weight management for beneficiaries with a BMI of 30+ or 27+ with weight-related comorbidities.

Commercial insurance: Coverage continues to expand. As of late 2025, approximately 55 percent of large employer plans cover GLP-1s for weight loss, up from 38 percent in 2023.

Medicaid: Coverage varies dramatically by state.

Tricare and VA: Both cover Wegovy when medically necessary.

To check your specific coverage, call the member services number on the back of your insurance card and ask:

1. Is Wegovy covered on my plan's formulary for weight loss?
2. Does it require prior authorization?
3. What is my expected out-of-pocket cost after the deductible?

Find Affordable Wegovy Providers

Looking for an affordable provider? Take our 60-second provider quiz to match with the cheapest telehealth provider for your needs, or browse our complete telehealth provider comparison to see semaglutide pricing across 14 vetted platforms.

For in-person care, browse our directory of 9,700+ verified GLP-1 clinics across all 50 states.

For more on weight loss medication pricing, see our complete cost guide, Zepbound cost breakdown, and Zepbound vs Wegovy comparison.

---

This article is for informational purposes only and does not constitute medical advice. Pricing reflects publicly available information as of April 2026 and may change. Always verify current pricing with the manufacturer, your pharmacy, and your insurance provider before starting treatment.

Sources

1. Novo Nordisk Wegovy prescribing information and savings program terms, 2026.
2. NovoCare Pharmacy direct-to-consumer pricing, retrieved April 2026.
3. CMS guidance on Medicare Part D coverage of GLP-1 medications for weight loss, January 2026.
4. GLP1 Clinics telehealth provider pricing database, April 2026.
5. Kaiser Family Foundation employer health benefits survey, 2025.